To evaluate the efficacy and the safety profile of Rhubarb and alpha-Keto amino acid supplementation on patients of Chronic kidney disease.
Phase 4
Completed
- Conditions
- Health Condition 1: null- Chronic kidney disease
- Registration Number
- CTRI/2012/09/002947
- Lead Sponsor
- Department Of Pharmacology And Department Of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
•Chronic kidney disease of different etiology, before ESRD.
•Patient not on dialysis.
Exclusion Criteria
•Pregnancy
•Acute infection
•Psychotic patient
•Critically ill patient
•HIV/HBsAg/Anti-HCV and immunocompromised patient.
•Severe Renal pathology such as malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Haemogram <br/ ><br>2.Urine- Routine & Microscopic <br/ ><br>3.Blood Glucose <br/ ><br>4.Total Urine Protein(TUP) <br/ ><br>5.Blood Urea <br/ ><br>6.Serum Creatinine <br/ ><br>7.Urine Creatinine <br/ ><br>Timepoint: Pre-dose and after 1st 2nd 3rd month after starting dosing
- Secondary Outcome Measures
Name Time Method 1.USG-Both kidneys <br/ ><br>2.Chest X-ray( PA VIEW) <br/ ><br>Timepoint: Pre-dose and after 3 month post-dose.